4-(6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide,
CT 53518,
CT-53518,
CT53518,
MLN 518,
MLN-518,
MLN518,
tandutinib,
Tandutinib,
387867-13-2,
MLN-518,
Tandutinib (MLN518),
MLN518,
CT53518,
MLN 518,
CT 53518,
UNII-E1IO3ICJ9A,
4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide,
CT-53518,
E1IO3ICJ9A,
N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide,
CHEMBL124660,
CHEBI:90237,
MLN-0518,
MFCD09954147,
NSC726292,
(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide,
NCGC00241097-01,
DSSTox_CID_28873,
DSSTox_RID_83142,
DSSTox_GSID_48947,
Q-201778,
4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-(4-propan-2-yloxyphenyl)-1-piperazinecarboxamide,
4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide,
CAS-387867-13-2,
Tandutinib [USAN:INN],
tandutinibum,
Kinome_3320,
MLN518, Tandutinib,
Tandutinib(MLN518),
Tandutinib - MLN518,
Tandutinib(CT 53518),
AC1MI50F,
cc-355,
MLS006010972,
SCHEMBL927974,
DTXSID8048947,
BDBM13535,
cid_3038522,
CTK8E8817,
AOB5045,
SYN1088,
TANDUTINIB (CT53518),
BCPP000051,
HMS3244A21,
HMS3244A22,
HMS3244B21,
HMS3264G08,
HMS3654O09,
Pharmakon1600-01502277,
BCP01370,
EX-A1637,
KS-00000XG3,
ZINC3966243,
Tox21_113366,
NSC759851,
s1043,
AKOS015902621,
Tox21_113366_1,
AC-1659,
CCG-213017,
CS-0128,
DB05465,
ES-0051,
NSC-726292,
NSC-759851,
SB19380,
NCGC00241097-02,
NCGC00241097-03,
NCGC00241097-07,
AK326127,
AN-14710,
BC681887,
HY-10202,
SC-23292,
SMR004702776,
AB0073004,
RT-015876,
B1526,
FT-0653217,
SW218125-2,
EC-000.2262,
D06005,
F10205,
Tandutinib pound MLN518, CT53518 pound(c),
W-5432,
AB01562955_01,
867T132,
A824282,
I14-1975,
BRD-K89162000-001-01-5,
MLN518;CT53518;MLN 518;CT 53518;MLN-518;CT-53518,
1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-,
4-(6-Methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(1-methylethoxy)phenyl)piperazine-1-carboxamide,
4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide,
4-[7-(3-Piperidin-1-yl-propoxy)-quinazolin-4-yl]-piperazine-1-carboxylic acid (4-isopropoxy-phenyl)-amide,
N-(4-isopropoxyphenyl)-4-[6-methoxy-7-(3-piperidinopropoxy)quinazolin-4-yl]piperazine-1-carboxamide,
N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide,
Tandutinib [USAN],
Tandutinib (USAN/INN),
C31H42N6O4,
C31-H42-N6-O4,
ACN-040202,
CID3038522,
A10887,
4-[6-Methoxy-7- quinazolin-4-yl]-N- piperazine-1-carboxamide,